Midwest Trust’s Sanofi SNY Stock Holding History

Midwest Trust’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,724	Closed	-$229K	–	615
2025 Q4	$229K	Buy	+4,724	New	+$234K	﹤0.01%	560
2025 Q3	–	Sell	-8,888	Closed	-$429K	–	608
2025 Q2	$429K	Buy	+8,888	New	+$454K	0.01%	447

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Midwest Trust's SNY Position: Q1 2026 in Review

Midwest Trust sold out of Sanofi (SNY) in Q1 2026, closing a stake of 4,724 shares — an estimated $229K sold.

Midwest Trust first reported a position in SNY in Q2 2025 and held it in 2 quarters. The position peaked at $429K in Q2 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Midwest Trust reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
Midwest Trust sold 4,724 Sanofi shares in Q1 2026, an estimated $229K.
Midwest Trust first reported a position in Sanofi in Q2 2025 and held it in 2 quarters.
Midwest Trust's Sanofi position peaked at $429K in Q2 2025.
738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.